The inhalation route is frequently used to administer drugs for the management of respiratory diseases such as asthma or chronic obstructive pulmonary disease. Compared with other routes of administration, inhalation offers a number of advantages in the treatment of these diseases. For example, via inhalation, a drug is directly delivered to the target organ, conferring high pulmonary drug concentrations and low systemic drug concentrations. The cover story of this month titled: “Inhaled drug delivery: Avoids the risk of absorption in the gastrointestinal tract and can accelerate targeted onset in certain therapeutic areas” as an interaction with Mark Copley -Chief Executive Officer at Copley Scientific. The edition has a featured article entitled “SMART Designs Tool to Investigate Bacteria Behind Hospital Infections contributed by Singapore-MIT Alliance for Research and Technology SMART is MIT’s Research Enterprise in Singapore, established by the Massachusetts Institute of Technology MIT.